Annual FCF
-$58.82 M
-$6.58 M-12.60%
December 31, 2023
Summary
- As of February 7, 2025, DSGN annual free cash flow is -$58.82 million, with the most recent change of -$6.58 million (-12.60%) on December 31, 2023.
- During the last 3 years, DSGN annual FCF has fallen by -$50.07 million (-572.57%).
- DSGN annual FCF is now -42213.67% below its all-time high of -$139.00 thousand, reached on December 31, 2019.
Performance
DSGN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$9.53 M
+$1.89 M+16.56%
September 30, 2024
Summary
- As of February 7, 2025, DSGN quarterly free cash flow is -$9.53 million, with the most recent change of +$1.89 million (+16.56%) on September 30, 2024.
- Over the past year, DSGN quarterly FCF has increased by +$1.89 million (+16.56%).
- DSGN quarterly FCF is now -629.15% below its all-time high of -$1.31 million, reached on June 30, 2020.
Performance
DSGN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$46.41 M
+$5.06 M+9.83%
September 30, 2024
Summary
- As of February 7, 2025, DSGN TTM free cash flow is -$46.41 million, with the most recent change of +$5.06 million (+9.83%) on September 30, 2024.
- Over the past year, DSGN TTM FCF has increased by +$5.06 million (+9.83%).
- DSGN TTM FCF is now -1645.39% below its all-time high of -$2.66 million, reached on March 31, 2020.
Performance
DSGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
DSGN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.6% | +16.6% | +9.8% |
| 3 y3 years | -572.6% | -4.4% | -91.8% |
| 5 y5 years | -10000.0% | -258.4% | -1645.4% |
DSGN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.3% | at low | at high | +45.6% | -50.1% | +24.4% |
| 5 y | 5-year | <-9999.0% | at low | -629.1% | +45.6% | -1645.4% | +24.4% |
| alltime | all time | <-9999.0% | at low | -629.1% | +45.6% | -1645.4% | +24.4% |
Design Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.53 M(-16.6%) | -$46.41 M(-9.8%) |
| Jun 2024 | - | -$11.42 M(-9.6%) | -$51.47 M(-4.6%) |
| Mar 2024 | - | -$12.63 M(-1.5%) | -$53.94 M(-8.3%) |
| Dec 2023 | -$58.82 M(+12.6%) | -$12.82 M(-12.1%) | -$58.82 M(-4.2%) |
| Sep 2023 | - | -$14.59 M(+5.0%) | -$61.37 M(+0.6%) |
| Jun 2023 | - | -$13.89 M(-20.7%) | -$60.99 M(+5.4%) |
| Mar 2023 | - | -$17.51 M(+13.9%) | -$57.84 M(+10.7%) |
| Dec 2022 | -$52.23 M | -$15.38 M(+8.2%) | -$52.23 M(+12.5%) |
| Sep 2022 | - | -$14.21 M(+32.3%) | -$46.44 M(+12.3%) |
| Jun 2022 | - | -$10.74 M(-9.7%) | -$41.36 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.90 M(+24.2%) | -$39.09 M(+26.4%) |
| Dec 2021 | -$30.91 M(+253.5%) | -$9.58 M(+4.9%) | -$30.91 M(+27.8%) |
| Sep 2021 | - | -$9.13 M(+7.8%) | -$24.19 M(+42.5%) |
| Jun 2021 | - | -$8.47 M(+127.1%) | -$16.98 M(+73.0%) |
| Mar 2021 | - | -$3.73 M(+30.5%) | -$9.82 M(+12.2%) |
| Dec 2020 | -$8.74 M(+6191.4%) | -$2.86 M(+48.8%) | -$8.74 M(+48.5%) |
| Sep 2020 | - | -$1.92 M(+47.0%) | -$5.89 M(+48.4%) |
| Jun 2020 | - | -$1.31 M(-50.8%) | -$3.97 M(+49.2%) |
| Mar 2020 | - | -$2.66 M | -$2.66 M |
| Dec 2019 | -$139.00 K | - | - |
FAQ
- What is Design Therapeutics annual free cash flow?
- What is the all time high annual FCF for Design Therapeutics?
- What is Design Therapeutics annual FCF year-on-year change?
- What is Design Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Design Therapeutics?
- What is Design Therapeutics quarterly FCF year-on-year change?
- What is Design Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Design Therapeutics?
- What is Design Therapeutics TTM FCF year-on-year change?
What is Design Therapeutics annual free cash flow?
The current annual FCF of DSGN is -$58.82 M
What is the all time high annual FCF for Design Therapeutics?
Design Therapeutics all-time high annual free cash flow is -$139.00 K
What is Design Therapeutics annual FCF year-on-year change?
Over the past year, DSGN annual free cash flow has changed by -$6.58 M (-12.60%)
What is Design Therapeutics quarterly free cash flow?
The current quarterly FCF of DSGN is -$9.53 M
What is the all time high quarterly FCF for Design Therapeutics?
Design Therapeutics all-time high quarterly free cash flow is -$1.31 M
What is Design Therapeutics quarterly FCF year-on-year change?
Over the past year, DSGN quarterly free cash flow has changed by +$1.89 M (+16.56%)
What is Design Therapeutics TTM free cash flow?
The current TTM FCF of DSGN is -$46.41 M
What is the all time high TTM FCF for Design Therapeutics?
Design Therapeutics all-time high TTM free cash flow is -$2.66 M
What is Design Therapeutics TTM FCF year-on-year change?
Over the past year, DSGN TTM free cash flow has changed by +$5.06 M (+9.83%)